These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 20550510)

  • 21. Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues.
    González-Díaz H; Romaris F; Duardo-Sanchez A; Pérez-Montoto LG; Prado-Prado F; Patlewicz G; Ubeira FM
    Curr Pharm Des; 2010; 16(24):2737-64. PubMed ID: 20642428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. QSAR Methods.
    Gini G
    Methods Mol Biol; 2016; 1425():1-20. PubMed ID: 27311459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Bioactive Scaffolds Based on QSAR Models.
    Nakagawa T; Miyao T; Funatsu K
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29135084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational Design of Multi-Target Estrogen Receptors ERα and ERβ by QSAR Approaches.
    Zhao Q; Lu Y; Zhao Y; Li R; Luan F; Cordeiro MN
    Curr Drug Targets; 2017; 18(5):576-591. PubMed ID: 27033186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational drug discovery.
    Ou-Yang SS; Lu JY; Kong XQ; Liang ZJ; Luo C; Jiang H
    Acta Pharmacol Sin; 2012 Sep; 33(9):1131-40. PubMed ID: 22922346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Public databases of plant natural products for computational drug discovery.
    Tung CW
    Curr Comput Aided Drug Des; 2014; 10(3):191-6. PubMed ID: 24724941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Analysis of QSAR-based vs. Chemical Similarity Based Predictors of GPCRs Binding Affinity.
    Luo M; Wang XS; Tropsha A
    Mol Inform; 2016 Jan; 35(1):36-41. PubMed ID: 27491652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization methods for virtual screening on novel computational architectures.
    Pérez-Sánchez H; Wenzel W
    Curr Comput Aided Drug Des; 2011 Mar; 7(1):44-52. PubMed ID: 20883205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Latest advances in molecular topology applications for drug discovery.
    Zanni R; Galvez-Llompart M; García-Domenech R; Galvez J
    Expert Opin Drug Discov; 2015; 10(9):945-57. PubMed ID: 26134383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico exploration of c-KIT inhibitors by pharmaco-informatics methodology: pharmacophore modeling, 3D QSAR, docking studies, and virtual screening.
    Chaudhari P; Bari S
    Mol Divers; 2016 Feb; 20(1):41-53. PubMed ID: 26416560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QSAR modeling of GPCR ligands: methodologies and examples of applications.
    Tropsha A; Wang SX
    Ernst Schering Found Symp Proc; 2006; (2):49-73. PubMed ID: 17703577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virtual screening and its integration with modern drug design technologies.
    Guido RV; Oliva G; Andricopulo AD
    Curr Med Chem; 2008; 15(1):37-46. PubMed ID: 18220761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in Drug Discovery and Design using Computer-aided Molecular Modeling.
    Singh K; Bhushan B; Singh B
    Curr Comput Aided Drug Des; 2024; 20(5):697-710. PubMed ID: 37711101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computer-Aided Drug Design: An Overview.
    Talevi A
    Methods Mol Biol; 2018; 1762():1-19. PubMed ID: 29594764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cheminformatics in the Identification of Drug Classes for the Treatment of Type 2 Diabetes.
    Finn PW
    Methods Mol Biol; 2020; 2076():71-84. PubMed ID: 31586322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applications of Quantitative Structure-Activity Relationships (QSAR) based Virtual Screening in Drug Design: A Review.
    Achary PGR
    Mini Rev Med Chem; 2020; 20(14):1375-1388. PubMed ID: 32348219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative structure-activity relationship models for compounds with anticonvulsant activity.
    Bellera CL; Talevi A
    Expert Opin Drug Discov; 2019 Jul; 14(7):653-665. PubMed ID: 31072145
    [No Abstract]   [Full Text] [Related]  

  • 39. 4D- quantitative structure-activity relationship modeling: making a comeback.
    Fourches D; Ash J
    Expert Opin Drug Discov; 2019 Dec; 14(12):1227-1235. PubMed ID: 31513441
    [No Abstract]   [Full Text] [Related]  

  • 40. Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR.
    Tropsha A; Isayev O; Varnek A; Schneider G; Cherkasov A
    Nat Rev Drug Discov; 2024 Feb; 23(2):141-155. PubMed ID: 38066301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.